The Great Pharma Race: GLP-1s, Billions, and the Battle for What's Next

Eli Lilly Slashes Zepbound Prices Amid Political Pressure and Trump's Claims

The Next Frontier: Unpacking 'Ozempic 2.0' and the Future of Weight Management

Unanimous Picks: Why Top Funds Are Doubling Down on These Six Stocks

A New Era for Weight Loss: The Revolution of GLP-1 Pills and Monthly Shots

Eli Lilly's Short-Term Horizon: A Look at Market Expectations

Modern Health's Crossroads: Unpacking Ultra-Processed Food Warnings and the Egg Freezing Debate

Eli Lilly's Trillion-Dollar Triumph: Reshaping the Pharma Landscape

The Trillion-Dollar Bet: How Eli Lilly is Reshaping the Global Economy

Eli Lilly's Trillion-Dollar Triumph: A New Chapter in Pharmaceutical History

The Pharma Giants' Bold Leap: Novo Nordisk and Eli Lilly Eyeing Direct Sales of Obesity Drugs to Employers

The Pharmaceutical Reckoning: How Weight Loss Breakthroughs Are Rewriting the Rules, One Pill (or Shot) at a Time

The $1,000 Question: Where Savvy Investors Are Parking Their Money for Tomorrow's Gains

Julianne Moore's Enduring Crusade: Beyond the Screen, Forging a Path to Brain Health

A Glimmer of Hope: Eli Lilly's Bold Leap into Gene Therapy for Blinding Eye Diseases

The GLP-1 Gold Rush: Will Trump Rewrite the Rules for Eli Lilly and Novo Nordisk?

The Billion-Dollar Battle for the Future of Weight Loss: Pfizer Jumps into the Ring

The Great Weight-Loss Gambit: Pfizer Jumps into the Billion-Dollar Battle for Obesity Treatment Supremacy

The Great Weight-Loss Race: Pfizer's Billion-Dollar Gambit to Conquer Obesity

The Lilly Lull: Why a Minor Dip Might Be Just a Blip in a Pharmaceutical Powerhouse's Journey

The Great Prescription Price Shake-Up: Could Trump's Bold Plan Reshape US Healthcare?

The Price of Progress? Unpacking the Billion-Dollar Buzz Around America's New Weight-Loss Fixes

The GLP-1 Gambit: Pharma Giants, Trump, and the High Stakes of Drug Prices

The Great Negotiation: Big Pharma, Weight Loss, and the White House

The Grand Alliance: Eli Lilly, NVIDIA, and the Supercomputer Set to Reshape Medicine

A Tsunami of Pills: Eli Lilly's Grand Plan to Conquer the Weight Loss Market

A New Horizon in the Battle Against Alzheimer's: Hope Arrives, But Not Without Hurdles

A Breath of Relief: How Eli Lilly's Omvoh is Tackling Ulcerative Colitis Urgency Head-On

The Week That Was: Big Moves, Bold Bets, and Shifting Sands in the Corporate World

A Breakthrough Moment: Unpacking Olumiant's Promise for Young Lives Touched by Alopecia

The Revolving Door: Ex-FDA Regulators Find New Homes at Pharma Giants Like Eli Lilly

FDA Greenlights Groundbreaking Blood Test for Alzheimer's Disease

A New Era for Alzheimer's Diagnosis: FDA Approves First Blood Test

A New Dawn for Diagnostics: FDA Approves First Blood Test for Alzheimer's Disease

A New Dawn for Alzheimer's Diagnosis: FDA Approves Roche and Eli Lilly's Groundbreaking Blood Test

UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment

A New Chapter: Peter Marks, Former FDA Vaccine Czar, Lands at Eli Lilly

A Billion-Dollar Bet: Eli Lilly's Monumental Investment Ignites India's Pharma Future

Eli Lilly Unveils $1 Billion India Investment to Supercharge Mounjaro Production